Telix Pharmaceuticals Limited (TLX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Telix Pharmaceuticals Limited, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -354.82x | 165.07x | 1361.87x | -66.32x | -73.05x | -112.84x |
| P/B Ratio | 6.09x | 14.50x | 47.66x | 86.27x | 2725.51x | 64.10x |
| P/S Ratio | 3.15x | 10.52x | 14.12x | 43.11x | 774.31x | 971.61x |
| Profitability | ||||||
| Gross Margin | 53.1% | 65.1% | 62.6% | 18.3% | -391.9% | -323.7% |
| Operating Margin | 2.2% | 10.5% | 10.3% | -57.4% | -1069.6% | -944.8% |
| Net Margin | -0.9% | 6.4% | 1.0% | -65.0% | -1059.9% | -861.1% |
| EBITDA Margin | 6.6% | 12.5% | 4.6% | -58.0% | -922.5% | -862.1% |
| Liquidity | ||||||
| Current Ratio | 1.43x | 2.78x | 1.43x | 2.02x | 1.25x | 4.69x |
| Quick Ratio | 1.27x | 2.66x | 1.32x | 1.96x | 1.16x | 4.66x |
| Leverage | ||||||
| Debt/Equity | 1.26x | 1.02x | 0.12x | 0.13x | 1.18x | 0.03x |
YoY = year-over-year change. Source: FMP..